Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Alcohol Misuse in Cirrhosis
NCT03416751Phase 1Completed
- Sponsor
- Richmond VA Medical Center
- Start
- Feb 2018
- Primary completion
- Apr 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in alcohol use disorder (AUD) and Cirrhosis comparing Fecal Microbial transplantation with Placebo (2 arms). Primary endpoints: Proportion of participants with a related serious adverse event at 15 days, Proportion of participants with newly acquired transmissible infectious diseases at 15 days and 1 more. Started Feb 2018; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
alcohol use disorder (AUD)Cirrhosis
Beyond the preview
Go deeper on NCT03416751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416751.